Preparation and evaluation of ketoconazole-β-cyclodextrin multicomponent complexes

International Journal of Pharmaceutics

Volumn 142, Issue 2, 1996, Pages 183-187

  Esclusa Diaz M T ^a   Gayo Otero, M ^a   Perez Marcos M B ^a   Vila Jato, J L ^a   Torres Labandeira, J J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Dissolution properties; Ketoconazole; Multicomponent systems; Solubility; Cyclodextrin complexes

Indexed keywords

BETA CYCLODEXTRIN; KETOCONAZOLE;

ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG SOLUBILITY; PRIORITY JOURNAL; X RAY DIFFRACTION;

EID: 0030580115     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04666-2     Document Type: Article

References (10)

1. De Beule, K., The role of Encapsin™ HPB (hydroxypropyl-β-cyclodextrin) in the development of itraconazole. Abstracts of The 8th International Cyclodextrin Symposium, Budapest, 30 March-2 April 1996.
2. Fenyvesi, E., Vikmon, M., Kolbe, I., Szejtli, J., Passini, M. and Ventura, P., Multicomponent complex formation with soluble cyclodextrin derivatives for the improvement of drug solubility. Abstracts of The 8th International Cyclodextrin Symposium, Budapest, 30 March-2 April 1996.
3. Higuchi T. and Connors K.A., Phase solubility techniques. Adv. Anal. Chem. Instrum., 4 (1965) 117-212.
4. Khan K.A., The concept of dissolution efficiency. J. Pharm. Pharmacol., 27 (1975) 48-49.
5. Nogami H., Nagai T. and Yotsuyanagi, T., Dissolution phenomena of organic medicinals involving simultaneous phase changes. Chem. Pharm. Bull., 17 (1969) 499-509.
6. Otero Espinar, F.J., Anguiano Igea, S., Torres Labandeira, J.J., Blanco Méndez, J. and Vila Jato, J.L., Influence of the pH medium on the obtention of inclusion compounds by the coprecipitation method. Proceedings of the 5th International Conference on Pharmaceutical Technology, Paris, 1989, pp. 137-143.
7. Pedersen, M., Isolation and antimycotic effect of a genuine miconazole b-cyclodextrin complex. Eur. J. Pharm. Biopharm., 40 (1994) 19-23.
8. Szejtli, J., Cyclodextrins in drug formulations: Part I. Pharm. Technol. Int., 3(2) (1991) 15-22.
9. Szente L., Szejtli J., Vikmon M., Szemán J., Fenyvesi e., Pasini M., Redenti E. and Ventura P., Proceedings of the 1st World Meeting APGI/APV, Budapest, 1995, p. 579.
10. Van der Meer J.W.M., Keuning J.J., Scheijgrond H.W., Heykants J., Van Cutsem J. and Brugmans J., The influence of gastric acidity on the bioavailability of ketoconazole. J. Antimicrob. Chemother., 6 (1980) 552-554.